A panel of experts convened by NJBIZ explained why the practice should remain a part of care offerings, even after the pandemic

The Kenilworth-based drugmaker said it saw “compelling results” in trials for molnupiravir, which reduced the risk of hospital or death by roughly 50% for those with mild to moderate cases of the virus.

The deal complements and strengthens the pharmaceutical giant's cardiovascular pipeline.

Steven Krefetz will support and advance the implementation of Inspira Health’s strategic plan by focusing on driving ambitious business growth and guiding the network on the path forward.

The largest gift ever given to any hospital in New Jersey will allow the former Saint Barnabas Medical Center to continue its ongoing transformation into an institution that provides quality and advanced care to the region.

The multi-year, multifaceted agreement will have the Woodbridge-based outlet serve as a state-wide resource for injury prevention and rehabilitation supporting the student-athletes.

Nicole Hayes joins the Whippany-based company where she will develop and drive an integrated strategy that leverages a compelling narrative to generate positive content in paid, earned, shared and owned channels.

Experts from Hackensack Meridian Health, Holy Name, Caregility and Online Computers explored many aspects of health care technology during a virtual NJBIZ panel discussion on Sept. 28.

The Princeton-based company and professional soccer player Carli Lloyd will focus on empowering women to take ownership of their health and care options.

According to New Jersey Health Commissioner Judith Persichilli, upward of 1.1 million New Jerseyans could qualify to get the extra shot.

Jurors at the Philadelphia Court of Common Pleas found that Johnson’s Baby Powder is safe and does not cause cancer, the company said in a statement on the verdict.

The funding will support food and nutrition, STEM education, health and wellness and community development.